Regencell Bioscience Holdings Limited RGC Stock
24.3 USD
{{ price }}
3.272412%
{{change_pct}}%
SECTOR
Healthcare
COUNTRY
United States
Exchange
NasdaqCM
Market Cap
316.21M USD
LOW - HIGH [24H]
22
-
27 USD
VOLUME [24H]
86.45K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.33 USD
Regencell Bioscience Holdings Limited Price Chart
Regencell Bioscience Holdings Limited RGC Financial and Trading Overview
| Regencell Bioscience Holdings Limited stock price | 24.3 USD |
| Previous Close | 23.14 USD |
| Open | 23.92 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 23.92 - 23.92 USD |
| 52 Week Range | 21.67 - 46 USD |
| Volume | 215 USD |
| Avg. Volume | 957 USD |
| Market Cap | 311.27M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.33 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
RGC Valuation Measures
| Enterprise Value | 285.49M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 18.245615 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -38.23 |
Trading Information
Regencell Bioscience Holdings Limited Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -43.74% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 46 USD |
| 52 Week Low | 21.67 USD |
| 50-Day Moving Average | 25.18 USD |
| 200-Day Moving Average | 28.03 USD |
RGC Share Statistics
| Avg. Volume (3 month) | 957 USD |
| Avg. Daily Volume (10-Days) | 2.09K USD |
| Shares Outstanding | 13.01M |
| Float | 1.46M |
| Short Ratio | 4.31 |
| % Held by Insiders | 88.76% |
| % Held by Institutions | 0.0089% |
| Shares Short | 2.45K |
| Short % of Float | 0.10% |
| Short % of Shares Outstanding | 0.020% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -51.86% |
| Return on Equity (ttm) | -116.096% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -7467623 USD |
| Net Income Avi to Common (ttm) | -7445943 USD |
| Diluted EPS (ttm) | -0.57 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.42M USD |
| Total Cash Per Share (mrq) | 1.26 USD |
| Total Debt (mrq) | 771.26K USD |
| Total Debt/Equity (mrq) | 4.52 USD |
| Current Ratio (mrq) | 28.462 |
| Book Value Per Share (mrq) | 1.311 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5267055 USD |
| Levered Free Cash Flow (ttm) | -2688865 USD |
Profile of Regencell Bioscience Holdings Limited
| Country | United States |
| State | N/A |
| City | Causeway Bay |
| Address | First Commercial Building |
| ZIP | N/A |
| Phone | 852 2155 0823 |
| Website | https://www.regencellbioscience.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 13 |
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Q&A For Regencell Bioscience Holdings Limited Stock
What is a current RGC stock price?
Regencell Bioscience Holdings Limited RGC stock price today per share is 24.3 USD.
How to purchase Regencell Bioscience Holdings Limited stock?
You can buy RGC shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Regencell Bioscience Holdings Limited?
The stock symbol or ticker of Regencell Bioscience Holdings Limited is RGC.
Which industry does the Regencell Bioscience Holdings Limited company belong to?
The Regencell Bioscience Holdings Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Regencell Bioscience Holdings Limited have in circulation?
The max supply of Regencell Bioscience Holdings Limited shares is 13.01M.
What is Regencell Bioscience Holdings Limited Price to Earnings Ratio (PE Ratio)?
Regencell Bioscience Holdings Limited PE Ratio is now.
What was Regencell Bioscience Holdings Limited earnings per share over the trailing 12 months (TTM)?
Regencell Bioscience Holdings Limited EPS is -0.33 USD over the trailing 12 months.
Which sector does the Regencell Bioscience Holdings Limited company belong to?
The Regencell Bioscience Holdings Limited sector is Healthcare.
Regencell Bioscience Holdings Limited RGC included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
| NYSE COMPOSITE (DJ) NYA | 18767.19 USD — |
-3.92
|
— — | — — | — — | — - | — — |
| NASDAQ HealthCare IXHC | 920.53 USD — |
-2.33
|
— — | 917.85 USD — | 930.28 USD — | — - | — — |
- {{ link.label }} {{link}}